NGD-2000-1

N/A

Report date: 2023/02/20 18:00:49
NME

Base Information

Drug NameNGD-2000-1
Drug Alias NameNGD-2000-1NDT-9509589
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurogen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurogen Corp
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A